newsfilter.io

Latest Interviews

Showing 1831–1845 of 5,336 transcripts.

Clear all filters
  1. The Economist23 min

    Scandal in the wind: Adani’s indictment could hurt Modi

    Adani, Modi, Jason Palmer, Rosie Bloor, Jeremy Page, Don Wineland, Katherine Nixie

    Following a BJP landslide in Maharashtra and a US indictment alleging a $250 million bribery scheme, Indian Prime Minister Narendra Modi faces intensifying political scrutiny as opposition leader Rahul Gandhi demands an investigation into the Adani conglomerate's alleged corruption. Simultaneously, China's real estate sector remains in deep crisis with 2.8 billion square meters of unsold inventory, a situation driven by restrictive debt policies and hampered by ineffective government interventions that have failed to clear housing stocks or restore consumer confidence. In the cultural sphere, psychologist Jordan Peterson continues to polarize public opinion through his new theological book and controversial rhetoric, sustaining a commercially lucrative ecosystem of followers and critics while navigating academic and societal backlash regarding his views on gender and free speech.

  2. All-In Podcast1h 10m

    DOGE unveils a roadmap, Unlocking GDP Growth, WW3 escalation, Fat cell memory

    Chamath, Friedberg, Jason Calacanis, David Sacks

    Elon Musk and Vivek Ramaswamy's Department of Government Efficiency plans to eliminate $500 billion in unauthorized federal spending over an 18-month period by leveraging recent Supreme Court rulings to bypass traditional legislative approval processes. The initiative targets regulatory rollbacks through executive audits and temporary payment suspensions while facing anticipated legal challenges from entrenched bureaucratic interests and internal Republican resistance to deficit reduction. Concurrently, the discussion highlights global security risks regarding Western missile capabilities in the Ukraine-Russia conflict and presents scientific breakthroughs in epigenetics that explain persistent obesity mechanisms despite weight loss.

  3. Milken Institute1h 0m

    Why Younger People Are Getting Cancer and What We Can Do About It | Future of Health Summit 2024

    Dylan Scott, Karen Knudsen, Harlan Levine, Mohit Manrao, Kimryn Rathmell, AmirAli Talasaz

    A comprehensive 24-million-person study spanning two decades reveals that 17 of 34 major cancer types are rising significantly among Millennials and Gen X, prompting the American Cancer Society to lower screening thresholds despite critical barriers in adoption and access. To address this "tsunami" of young survivors facing unique fertility, financial, and care challenges, the field is transitioning toward liquid biopsy innovations and multidisciplinary "living" guideline frameworks to bridge the gap between community providers and academic centers. While precision medicine and expanded immunotherapy trials offer hope for improved survival, the crisis persists due to outdated insurance models, systemic disparities, and a significant lag between emerging scientific evidence and updated clinical protocols.

  4. Goldman Sachs33 min

    Primavera Capital’s Fred Hu on China’s economic trajectory

    Fred Hu, Kevin Sneader

    Following a historic equity rally triggered by unprecedented joint policy directives from China's financial regulators and top leadership, Fred Hu of Primavera Capital Group characterizes the current market upturn as a normalization phase with substantial catch-up potential. Hu anticipates that near-term fiscal stimulus will target household consumption while arguing that long-term confidence depends on structural reforms that reassure the private sector and accelerate innovation in fields where China currently lags in generative AI. Beyond immediate market dynamics, the event highlights China's undisputed leadership in green energy and a massive demographic opportunity within its 800 million-person middle class, which analysts project will soon drive private consumption to become the primary engine of national GDP growth.

  5. Y Combinator42 min

    Vertical AI Agents Could Be 10X Bigger Than SaaS

    Gary, Jared Harge, Diana, Mark Mandelbaum, Aaron Cannon, Mike, Brett Taylor, Parker Conrad, Matt McGinnis, Salient, VAPI, Rippling, Speedy Brand, OpenAI, Claude, Melanie Warrick, Nico, A Priori, Capital.ai, PowerHelp, Giga ML, Zepto, Mementic, Rainforest QA, Triplebyte, Outset, Vector Shift, Mark Benioff, Paul Graham, Travis, Jake Heller, Flo Cravello, Tia, Hashi Roginio, Mark Mirchandani, Francesc Campoy Flores

    Jared Harge projects that vertical AI agents will trigger a $300 billion+ market surge by displacing human labor in specialized enterprise functions, mirroring the historical success of B2B SaaS where general-purpose incumbents cannot master niche domain complexities. While competitors like Mark Mandelbaum note exceptions such as Rippling's horizontal platform strategy, startups are advised to target high-value, repetitive workflows—from automated recruiting to debt collection—rather than competing in obvious consumer applications where incumbents like Google retain dominance. This shift from basic software wrappers to full-stack agents is expected to expand organizational leadership span and create unicorns ten times larger than previous software predecessors by integrating complex domain knowledge directly into autonomous decision-making tools.

  6. The Economist26 min

    Assisted dying: why Britain should back a change

    Rosie Bloor, Georgia Banjo, Kim Leadbeater, Stephen Mazey, Anne Rowe

    UK MPs will vote next week on a stringent assisted dying bill that restricts eligibility to terminally ill patients with less than six months to live and requires dual medical confirmation plus High Court approval, though Health Secretary Wes Streeting opposes the measure citing cost concerns. Parallel to this domestic debate, the US judicial landscape faces a potential consolidation of conservative power by 2028 if Donald Trump reopens a path to appointing over half the Supreme Court, which could remove internal checks on executive authority regarding issues like birthright citizenship. Meanwhile, the art world marks the death of Frank Auerbach, a German-Jewish refugee painter who passed away at 93 after decades of obsessively recreating North London street scenes through a destructive process of thickly layering and scraping paint.

  7. Sourcery with Molly O'Shea35 min

    How Armada Is Powering AI at the Edge | A Conversation with CEO Dan Wright

    Dan Wright, Molly O'Shea, Jon Runyan, Pradeep Nair

    Founded in 2022 by ex-AppDynamics CEO Dan and other industry veterans, Armada has secured $100 million to deploy its Commander platform, which unifies satellite connectivity, ruggedized mobile data centers known as Galleons, and AI operations for remote environments. The company targets the 70% of the globe beyond standard cellular networks, partnering with Starlink and Microsoft to deliver real-time industrial monitoring and safety solutions across nearly 50 countries. With a leadership team drawn from Microsoft Azure, SpaceX, and Okta, Armada aims to create a global distributed cloud that enables mission-critical AI applications in hostile locations ranging from Antarctica to offshore oil rigs.

  8. Goldman Sachs28 min

    Investing in Sports: A New Media Model

    Nicole Pullen Ross, Dave Dase, Gene Sykes

    Driven by lucrative 20-year media rights deals and the migration of distribution from legacy broadcasters to tech platforms, the sports industry is navigating a valuation surge that currently places the NBA at $76 billion. As cord-cutting erodes traditional cable bundles and regional networks collapse, leagues and legacy broadcasters are restructuring through direct-to-consumer streaming services and modified game rules to maximize subscriber engagement. This fundamental shift, supported by the expansion of sports betting and the growing global influence of athlete personal brands, is projected to continue driving team valuations upward over the next decade.

  9. Goldman Sachs30 min

    2025 outlook: Will tailwinds trump tariffs?

    Jan Hatzius, Dominic Wilson, Yann, Dom, Tom, David, Alec, Dami, Yuan

    Forecasts project U.S. real GDP growth at 2.5% for 2025, driven by real wage gains and moderate financial conditions, while maintaining a 15% recession probability. The outlook hinges on tariff scenarios, where base case assumptions assume limited trade barriers, though a full across-the-board tariff risk could reduce growth by one percentage point and raise inflation toward 3%. Consequently, investors are advised to hedge equity concentration risks with non-U.S. bonds and options while anticipating Federal Reserve rate cuts that target a federal funds range of 3.25% to 3.5% by late 2025.

  10. a16z12 min

    How GenAI-Based Software Is Advancing Marketing and Sales

    Seema Amble, Steph Smith

    With the global marketing industry expanding beyond $500 billion annually, professionals are rapidly transitioning from manual content creation to auditing roles driven by generative AI's capabilities in dynamic research and hyper-personalization. While small and medium businesses have quickly adopted automated agents to replace agency retainers, enterprise organizations lag due to concerns over brand risk and quality standards, keeping human oversight critical for the foreseeable future. Strategic adoption is now prioritized through immediate experimentation with AI tools, which are shifting the industry's value proposition toward data-driven decision-making and bridging sales-marketing integration despite remaining barriers regarding hallucination risks.

  11. Milken Institute54 min

    Connecting the Dots for Women's Health: Innovation, Access, & Care | Future of Health Summit 2024

    Ruth Reader, Sandra Brooks, Trish Costello, Jenica Patterson, Ana Maria Ramirez, Tammy Sun

    As of last week, ARPA-H has obligated $113 million in federal funding to support women's health research through Spark and Launchpad awards targeting conditions like Alzheimer's, endometriosis, and maternal mortality. This investment coincides with a 300% surge in venture capital for the sector since 2018, driving innovations in male contraception and non-pharmacological treatments despite persistent racial disparities and access barriers. While bipartisan funding provides short-term stability, experts warn that evolving legal landscapes regarding abortion and the politicization of data privacy pose significant risks to future reproductive health outcomes.

  12. Y Combinator23 min

    Twitter vs. X: Product Lessons For Startup Founders

    Tom Blomfield, David Lieb

    The presentation critiques the trend of optimizing social platforms for singular engagement metrics, arguing that this strategy degrades user satisfaction by creating "engagement farms" filled with low-quality content. Using Twitter's transformation under Elon Musk as a primary case study, the analysis highlights how shifting from a chronological feed to an algorithmic model has diluted content quality, confused verification systems, and likely reduced advertising revenue despite boosting raw usage time. Ultimately, the speaker advises product leaders to define clear "good states" for users and resist growth-at-all-costs pressures to ensure long-term retention and genuine value.

  13. The Economist22 min

    All for one: Donald Trump and his key Musketeer

    Donald Trump, Jason Palmer, Rosie Bloor, Patrick Fowles, Rachel Lloyd, Fraser McIlwraith

    Elon Musk is set to lead the new Department of Government Efficiency under President-elect Donald Trump, a partnership driven by shared hostility toward federal bureaucracy and "woke" culture despite risks of conflicts of interest and a volatile alliance dynamic. Concurrently, Ireland is confronting its history of Magdalene laundries through new criminal legislation prohibiting record destruction and plans for a remembrance center, though church-controlled education stalls broader reform. Finally, Chile is witnessing a surge in salmon theft as criminal networks pivot from timber to the lucrative aquaculture sector, prompting enhanced security measures and legislative proposals to address the rising crime wave.

  14. The Economist16 min

    How AI is revolutionising science

    Bear, Andy Davis, Alex Zarankov, Emily Shuckborough, Adi Rakhoum, Andy Cooper, Alok Jha

    Generative AI is revolutionizing scientific discovery by accelerating drug development, exemplified by Insilico Medicine's rapid creation of an IPF treatment, while simultaneously advancing climate modeling and animal communication research through sophisticated pattern recognition. Autonomous robotic labs and tools like AlphaFold are further democratizing innovation by processing vast datasets and conducting thousands of experiments, though this surge in capability has triggered significant concerns regarding research integrity and AI-generated fraud. As investment flows into these multidisciplinary fields, the industry faces critical challenges in establishing robust data standards and regulations to ensure these tools achieve the projected "golden age" of discovery without compromising scientific validity.

  15. Sequoia Capital53 min

    Natera ft. Matthew Rabinowitz - A Personal Mission That Led to a Biotech Revolution

    Matthew Rabinowitz, Roelof Botha, Jonathan Sheena, Steve Chapman, Chitra Kotwaliwale, Sarah Elliot, Rolof Buerta

    Co-founded by Matthew Rabinovitz and Jonathan Sheena, Natera has evolved from a specialized IVF testing provider into a global leader in genetic diagnostics, now processing 40% of U.S. pregnancies and capturing nearly half of oncologists' orders for its Signatera cancer monitoring test. The company successfully navigated significant financial volatility and strategic pivots to achieve a $1.5 billion revenue forecast, with its stock appreciating from $7 to over $100 per share following the clinical validation and market adoption of its oncology division. Today, Natera maintains a dominant market position in women's health genetics and minimal residual disease monitoring while leveraging AI to further expand its early detection capabilities across solid tumors.